2002
DOI: 10.1016/s1473-3099(02)00438-3
|View full text |Cite
|
Sign up to set email alerts
|

Pathogenesis of infections due to coagulasenegative staphylococci

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

10
494
3
11

Year Published

2004
2004
2010
2010

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 728 publications
(518 citation statements)
references
References 88 publications
10
494
3
11
Order By: Relevance
“…During the last two decades, coagulase-negative staphylococci (CNS) have also emerged as pathogens causing medical-device-related infections (von Eiff et al, 2002). Because of the pathogenic potential of these bacteria, effective methods are required for their in vitro identification.…”
Section: Introductionmentioning
confidence: 99%
“…During the last two decades, coagulase-negative staphylococci (CNS) have also emerged as pathogens causing medical-device-related infections (von Eiff et al, 2002). Because of the pathogenic potential of these bacteria, effective methods are required for their in vitro identification.…”
Section: Introductionmentioning
confidence: 99%
“…Since the early 1980s, it has gained substantial attention because it has been recognized as one of the most important causes of nosocomial infections (Vuong & Otto, 2002;Raad et al, 1998). S. epidermidis is mainly found in nosocomial cardiovascular infections, bloodstream infections and infections of the eye, ear, nose and throat (von Eiff et al, 2002).The staphylococcus accessory gene regulator (agr) locus is the most important locus responsible for growth-phasedependent regulation of virulence factors (Otto et al, 1998). The gene structure and sequences of the S. epidermidis agr system are very similar to those of Staphylococcus aureus, and the locus may play a comparable role.…”
mentioning
confidence: 99%
“…1 Como resultado, o tratamento das infecções bacterianas tem se tornado um desafio para os profissionais da saúde, cientistas e governantes, assim como para as indústrias farmacêuticas.…”
Section: Resultsunclassified
“…1 No final dos anos 80 e início dos anos 90, a comunidade médica foi surpreendida pelo aumento do número de doenças infecciosas causadas por cepas de MRSA multirresistentes. A vancomicina é o medicamento de primeira escolha no tratamento de infecções causadas por estes microrganismos.…”
Section: Introductionunclassified